Antifungal potential of disulfiram

Japanese Journal of Medical Mycology

Volumn 48, Issue 3, 2007, Pages 109-113

  Khan, Seema ^a   Singhal, Smita ^a   Mathur, Tarun ^a   Upadhyay, Dilip J ^a   Rattan, Ashok ^b  

^a RANBAXY RESEARCH LABORATORIES   (India)

^b Caribbean Epidemiology Centre   (Trinidad and Tobago)

Author keywords

Antifungal; Disulfiram; Fungicidal

Indexed keywords

ALCOBUSE; ALCOHOL; AMPHOTERICIN B; CASPOFUNGIN; CHRONOL; DISULFIRAM; FLUCONAZOLE; FUNGAL PROTEIN; GLYCOPROTEIN P; ITRACONAZOLE; PROTEIN CDR1P; UNCLASSIFIED DRUG; VORICONAZOLE; ANTIFUNGAL AGENT;

ALCOHOL ABUSE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; CRYPTOCOCCUS NEOFORMANS; DRUG BIOAVAILABILITY; DRUG POTENCY; DRUG SAFETY; DRUG SENSITIVITY; FUNGICIDAL ACTIVITY; FUNGUS ISOLATION; HISTOPLASMA CAPSULATUM; HUMAN; IC 50; IC 90; MINIMUM INHIBITORY CONCENTRATION; STRAIN IDENTIFICATION; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; REVIEW; YEAST;

ASPERGILLUS;

ANTIFUNGAL AGENTS; ASPERGILLUS; DISULFIRAM; MICROBIAL SENSITIVITY TESTS; YEASTS;

EID: 34548554575     PISSN: 09164804     EISSN: None     Source Type: Journal    
DOI: 10.3314/jjmm.48.109     Document Type: Article

References (19)

1. Denning D: Epidemiology and pathogenesis of systemic fungal infection in the immunocompromised host. J Antimicrob Chemother 28 (Suppl B): 1-16, 1991.
2. Berrouane YF, Herwaldt LA, Pfaller MA: Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital. J Clin Microbiol 37: 531-537, 1999.
3. Groll AH, Kurz M, Schneider W, Witt V, Schmidt H, Schneider M, Schwabe D: Five-year-survey of invasive aspergillosis in a pediatric cancer center. Epidemiology, management and long-term survival. Mycoses 42: 431-442, 1999.
4. Ghannoum MA, Rice LB: Antifungal agents: mode of action, mechanism of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 12: 501-517, 1999.
5. Kontoyiannis DP, Lewis RE: Antifungal drug resistance of pathogenic fungi. Lancet 359: 1135-1144, 2002.
6. Sanglard D, Odds FC: Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2: 73-85, 2002.
7. Sterling TR, Merz WG: Resistance to amphotericin B: emerging clinical and morphological patterns. Drug Resist Updates 1: 161-165, 1998.
8. Mehta RT, Hopfer RL, Gunner LA, Juliano RL, Lopez-Berestein G: Formulation, toxicity, and antifungal activity in-vitro of liposome-encapsulated nystatin as therapeutic agent for systemic candidiasis. Antimicrob Agents Chemother 31: 1897-1900, 1987.
9. Wermuth CG: Selective optimization of side activities: Another way of drug discovery. J Med Chem 47: 1-12, 2004.
10. Borges-Walmsley MI, Walmsley AR: The structure and function of drug pumps. Trends in Microbiol 9: 71-78, 2001.
11. Nakamura K, Niimi M, Niimi K, Holmes AR, Yates JE, Decottignies A, Monk BC, Goffeau A, Cannon RD: Functional expression of Candida albicans efflux pump CDR1p in Saccharomyces cerevisiae strain deficient in membrane transporters Antimicrob Agents Chemother 45: 3366-3374, 2002.
12. Albertson GD, Niimi M, Cannon RD, Jenkinson HF: Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob Agents Chemother 40: 2835-2841, 1996.
13. Maesaki S, Marichal P, Hossain MA, Sanglard D, Vanden Bossche H, Kohno S: Synergic effects of tacrolimus and azole antifungal agents against azole-resistant Candida albicans strains. J Antimicrob Chemother 42: 747-753, 1998.
14. Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J: Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39: 2378-2386, 1995.
15. Prasad, R., De Wergifosse, P., Goffeau, A., Balzi, E: Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genetics 27: 320-329. 1995.
16. Sauna ZE, Xiang-Hong P, Krishnamachary N, Tekle S, Ambudkar SV: The molecular basis of the action of disulfiram as a modulator of the multidrug resistance-linked ATP binding cassette transporters MDR1 (ABCB1) and MRP1 (ABCC1). Mol Pharmacol 65: 675-684, 2004.
17. Sauna ZE, Shukla S, Ambudkar SV: Disulfiram, an old drug with new potential therapeutic uses for human cancers and fungal infections. Mol Biosyst 1: 127-134, 2005.
18. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. Document M27-A. National Committee for Clinical Laboratory Standards., Wayne, Pa18. 1997.
19. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidiaforming filamentous fungi. Proposed Standard. Document M38-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.18, 2001.